What is ATEC's health score?

Alphatec Holdings, Inc. (ATEC) has a TradeApes health score of 43 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ATEC's estimated fair value?

Based on our 5-year discounted cash flow model, Alphatec Holdings, Inc.'s estimated fair value is $7.02 per share, representing a -11.4% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ATEC undervalued or overvalued?

Our model currently rates ATEC as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ATEC... Refresh in a moment for the full analysis.

Alphatec Holdings, Inc. (ATEC)

Healthcare Overvalued low weak

$7.92

Updated: 2026-06-05

TradeApes Score

Financial Strength

15 Stressed

Operating Trend

40 Weak

Relative Value

60 Healthy

Capital Allocation

40 Weak

Risk

80 Strong

Est. Fair Value $7.02

DCF Upside -11.4%

Sector Rank #5086 of 6908

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.